0001214659-19-007463.txt : 20191129
0001214659-19-007463.hdr.sgml : 20191129
20191129134115
ACCESSION NUMBER: 0001214659-19-007463
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191126
FILED AS OF DATE: 20191129
DATE AS OF CHANGE: 20191129
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Finn Patrick John
CENTRAL INDEX KEY: 0001755970
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 191260800
MAIL ADDRESS:
STREET 1: C/O TWIST BIOSCIENCE CORPORATION
STREET 2: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-46429.xml
PRIMARY DOCUMENT
X0306
4
2019-11-26
0001581280
Twist Bioscience Corp
TWST
0001755970
Finn Patrick John
C/O TWIST BIOSCIENCE CORPORATION
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
Chief Commercial Officer
Common Stock
2019-11-26
4
M
false
33000
5.95
A
75596
D
Common Stock
2019-11-27
4
S
false
36932
23.3199
D
38664
D
Employee Stock Option (right to buy)
5.95
2019-11-26
4
M
false
33000
0
D
2025-09-29
Common Stock
33000
6875
D
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
Represents the aggregate of sales effected on the same day at different prices.
Represents the weighted average sales price per share. The shares sold at prices ranging from $23.00 to $23.75 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
The option is immediately exercisable. 25% of the shares subject to the option vested on September 01, 2016, and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
/s/ William Solis, as Attorney-in-Fact for Patrick John Finn
2019-11-29